Investing Ideas
/
Indonesian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Indonesian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

High return on equity, past performance and sound balance sheet.

1 companies

Merck

Market Cap: Rp1.5t

Engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally.

MERK

Rp3,240.00

0.9%

-9.7%